Free Trial
NASDAQ:GNOM

Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News

$7.29 -0.39 (-5.08%)
Closing price 03:59 PM Eastern
Extended Trading
$7.30 +0.00 (+0.07%)
As of 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)

Key Stats

Today's Range
$7.21
$7.54
50-Day Range
$7.29
$10.25
52-Week Range
$7.20
$11.88
Volume
107,989 shs
Average Volume
62,724 shs
Market Capitalization
$47.24 million
Assets Under Management
$46.54 million
Dividend Yield
0.00%
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

Remove Ads

Global X Genomics & Biotechnology ETF Expenses

TypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.57%0.56%0.53%0.53%
Other Expenses0.00%0.57%0.49%0.43%0.52%
Total Expense0.50%0.73%0.72%0.68%0.71%
Fee Waiver0.00%-0.72%-0.50%-0.30%-0.55%
Net Expense0.50%0.60%0.63%0.62%0.60%
Receive GNOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

GNOM ETF News Headlines

10x Genomics Misses Revenue Forecast
Global X Genomics & Biotechnology UCITS ETF (GNOM.L)
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
GNOM Global X Genomics & Biotechnology ETF
The Analyst Landscape: 4 Takes On 10x Genomics
See More Headlines

GNOM ETF - Frequently Asked Questions

Global X Genomics & Biotechnology ETF's stock was trading at $9.71 at the beginning of 2025. Since then, GNOM shares have decreased by 24.9% and is now trading at $7.29.
View the best growth stocks for 2025 here
.

Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global X Genomics & Biotechnology ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Teladoc Health (TDOC), Intel (INTC), Alibaba Group (BABA) and PayPal (PYPL).

Fund Details

Issuer
Global X
Fund Name
Global X Genomics & Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:GNOM
Inception Date
4/5/2019
Fund Manager
Chang Kim, James Ong, Nam To, Wayne Xie

Fund Focus

Asset Class
Equity
Benchmark
Solactive Genomics Index
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
42

Fund Statistics

Assets Under Management
$46.54 million
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
Global X Management Company LLC
Advisor
Global X Management Company LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
SEI Investments Distribution Co.
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
Optionable
Options Volume
5
Put Options
4
Call Options
1
Short Interest
16,400 shs

Miscellaneous

Beta
1.03
Creation Unit
50,000
Creation Fee
$500.00
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Top 10 GNOM Holdings

GNOM Sector Exposure

GNOM Industry Exposure


This page (NASDAQ:GNOM) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners